Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 491

1.

Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update.

Vamos M, Erath JW, Benz AP, Lopes RD, Hohnloser SH.

Am J Cardiol. 2019 Jan 1;123(1):69-74. doi: 10.1016/j.amjcard.2018.09.036. Epub 2018 Oct 4.

PMID:
30539748
2.

Uninterrupted anticoagulation with non-vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials.

Cardoso R, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, Okumura K, Nordaby M, Brouwer MA, Calkins H.

Clin Cardiol. 2018 Nov 20. doi: 10.1002/clc.23120. [Epub ahead of print] Review.

3.

Defibrillation testing and clinical outcomes after implantable cardioverter-defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial.

Bogdan S, Glikson M, Connolly SJ, Wang J, Hohnloser SH, Appl U, Neuzener J, Mabo P, Vinolas X, Gadler F, van Erven L, Kautzner J, Meeks B, Pogue J, Healey JS.

Heart Rhythm. 2018 Jul 29. pii: S1547-5271(18)30722-7. doi: 10.1016/j.hrthm.2018.07.030. [Epub ahead of print]

PMID:
30063996
4.

A randomized, double-blind, placebo-controlled trial assessing the efficacy of S66913 in patients with paroxysmal atrial fibrillation.

Camm JA, Dorian P, Hohnloser SH, Kowey PR, Tyl B, Ni Y, Vandzhura V, Maison-Blanche P, de Mellis M, Sanders P; DIAGRAF-IKUR study investigators.

Eur Heart J Cardiovasc Pharmacother. 2018 Jul 23. doi: 10.1093/ehjcvp/pvy022. [Epub ahead of print]

PMID:
30052825
5.

Syncope on exertion in a young male.

Erath JW, Puntmann VO, Chavakis E, Hohnloser SH.

HeartRhythm Case Rep. 2018 Apr 22;4(7):324-327. doi: 10.1016/j.hrcr.2018.04.005. eCollection 2018 Jul. No abstract available.

6.

Cephalic vs. subclavian lead implantation in cardiac implantable electronic devices: a systematic review and meta-analysis.

Benz AP, Vamos M, Erath JW, Hohnloser SH.

Europace. 2018 Jul 17. doi: 10.1093/europace/euy165. [Epub ahead of print]

PMID:
30020452
7.

Direct Oral Anticoagulants and Myocardial Infarction: The Dust Is Settling.

Hohnloser SH, Eikelboom JW.

J Am Coll Cardiol. 2018 Jul 3;72(1):27-28. doi: 10.1016/j.jacc.2018.04.037. No abstract available.

PMID:
29957228
8.

Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.

Wong JA, Conen D, Van Gelder IC, McIntyre WF, Crijns HJ, Wang J, Gold MR, Hohnloser SH, Lau CP, Capucci A, Botto G, Grönefeld G, Israel CW, Connolly SJ, Healey JS.

J Am Coll Cardiol. 2018 Jun 12;71(23):2603-2611. doi: 10.1016/j.jacc.2018.03.519.

PMID:
29880119
9.

Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE study.

Sandhu RK, Quadros KK, Liu YY, Glikson M, Kutyifa V, Mabo P, Hohnloser S, O'Hara G, VanErven L, Neuzner J, Kautzner J, Gadler F, Vinolas X, Appl U, Connolly SJ, Healey JS.

Europace. 2018 Nov 1;20(11):1798-1803. doi: 10.1093/europace/euy114.

PMID:
29878102
10.

ICD lead type and RV lead position in CRT-D recipients.

Benz AP, Vamos M, Erath JW, Bogyi P, Duray GZ, Hohnloser SH.

Clin Res Cardiol. 2018 Dec;107(12):1122-1130. doi: 10.1007/s00392-018-1286-3. Epub 2018 May 24.

PMID:
29797055
11.

Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT).

Perera KS, Sharma M, Connolly SJ, Wang J, Gold MR, Hohnloser SH, Lau CP, Van Gelder IC, Morillo C, Capucci A, Israel CW, Botto G, Healey JS.

Am Heart J. 2018 Jul;201:160-163. doi: 10.1016/j.ahj.2018.03.027. Epub 2018 Apr 18.

PMID:
29764671
12.

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.

Golwala HB, Cannon CP, Steg PG, Doros G, Qamar A, Ellis SG, Oldgren J, Ten Berg JM, Kimura T, Hohnloser SH, Lip GYH, Bhatt DL.

Eur Heart J. 2018 May 14;39(19):1726-1735a. doi: 10.1093/eurheartj/ehy162.

13.

Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.

Hohnloser SH, Camm J, Cappato R, Diener HC, Heidbuchel H, Lanz HJ, Mont L, Morillo CA, Smolnik R, Yin OQP, Kautzner J.

Clin Cardiol. 2018 Apr;41(4):440-449. doi: 10.1002/clc.22918. Epub 2018 Apr 17.

14.

Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time-A RE-LY trial analysis.

Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Yusuf S, Wallentin L.

Am Heart J. 2018 Apr;198:169-177. doi: 10.1016/j.ahj.2017.10.015. Epub 2018 Jan 5. No abstract available.

PMID:
29653640
15.

Digoxin and Mortality in Patients With Atrial Fibrillation.

Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L; ARISTOTLE Committees and Investigators.

J Am Coll Cardiol. 2018 Mar 13;71(10):1063-1074. doi: 10.1016/j.jacc.2017.12.060.

PMID:
29519345
16.

Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation.

Hohnloser SH, Basic E, Hohmann C, Nabauer M.

Thromb Haemost. 2018 Mar;118(3):526-538. doi: 10.1160/TH17-10-0733. Epub 2018 Jan 22.

PMID:
29359278
17.

Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy.

Vamos M, Healey JS, Wang J, Connolly SJ, Mabo P, Van Erven L, Kautzner J, Glikson M, Neuzner J, O'Hara G, Vinolas X, Gadler F, Hohnloser SH.

Heart Rhythm. 2018 Mar;15(3):386-392. doi: 10.1016/j.hrthm.2017.11.020. Epub 2017 Nov 20.

18.

Anticoagulation in atrial fibrillation : Current evidence and guideline recommendations.

Erath JW, Hohnloser SH.

Herz. 2018 Feb;43(1):2-10. doi: 10.1007/s00059-017-4648-0.

PMID:
29147720
19.

Off-Label Use of Direct Oral Anticoagulants in Intracerebral Hemorrhage Patients With Prosthetic Valves.

Chaturvedi S, Molina CA, Selim MH, Diener HC, Hohnloser SH.

Stroke. 2017 Nov;48(11):3183-3186. doi: 10.1161/STROKEAHA.117.017592. Epub 2017 Oct 13. No abstract available.

PMID:
29030474
20.

Usefulness of the WCD in patients with suspected tachymyopathy.

Erath JW, Vamos M, Benz AP, Hohnloser SH.

Clin Res Cardiol. 2018 Jan;107(1):70-75. doi: 10.1007/s00392-017-1159-1. Epub 2017 Oct 9.

PMID:
28993851

Supplemental Content

Loading ...
Support Center